The deletion polymorphism and Val1000Ile in α-2-macroglobulin and Alzheimer disease in Caribbean Hispanics

Neuroscience Letters

Volumn 279, Issue 3, 2000, Pages 133-136

  Romas, Stavra N ^a,b,c   Mayeux, Richard ^a,b,c   Rabinowitz, Daniel ^a   Tang, Ming Xin ^a,b   Rondon Zadroga, Haydee ^a,b   Lantigua, Rafael ^a,c   Medrano, Martin ^d   Tycko, Benjamin ^a,c   Knowles, James A ^a,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c NONE   (United States)

^d UNIVERSIDAD TECNOLÓGICA DE SANTIAGO   (Dominican Republic)

Author keywords

Alpha 2 macroglobulin; Alzheimer's disease; APOE 4; Caribbean Hispanics; Complex disease genetics; Family association; Odds ratio

Indexed keywords

ALPHA 2 MACROGLOBULIN;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; CARIBBEAN REGION; GENE DELETION; HISPANIC AMERICANS; HUMANS; MIDDLE AGED; NEW YORK CITY; POLYMORPHISM, GENETIC;

EID: 0033979472     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00972-6     Document Type: Article

References (19)

1. Aita V.M., Liu J., Knowles J.A., Terwilliger J.D., Baltazar R., Grunn A., Loth J.E., Kanyas K., Lerer B., Endicott J., Wang Z., Penchaszadeh G., Gilliam T.C., Baron M. A comprehensive linkage analysis of chromosome 21q22 supports prior evidence for a putative bipolar affective disorder locus. Am. J. Hum. Genet. 64:1999;210-217.
2. Blacker D., Wilcox M.A., Laird N.M., Rodes L., Horvath S.M., Go R.C., Perry R., Watson B. Jr., Bassett S.S., McInnis M.G., Albert M.S., Hyman B.T., Tanzi R.E. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19:1998;357-360.
3. Chen L., Baum L., Ng H.K., Chan L.Y., Sastre I., Artiga M.J., Valdivieso F., Bullido M.J., Chiu H.F., Pang C.P. Apolipoprotein E promoter and alpha2-macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease. Neurosci. Lett. 269:1999;173-177.
4. Crawford F., Town T., Freeman M., Schinka J., Gold M., Duara R., Mullan M. The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sample. Neurosci. Lett. 270:1999;133-136.
5. Dow D.J., Lindsey N., Cairns N.J., Brayne C., Robinson D., Huppert F.A., Paykel E.S., Xuereb J., Wilcock G., Whittaker J.L., Rubinsztein D.C. Alpha-2 macroglobulin polymorphism and Alzheimer disease risk in the UK (discussion pp. 21-22). Nat. Genet. 22:1999;16-17.
6. Goring H.H.H., Terwilliger J.D. Linkage analysis in the presence of errors IV: joint pseudomarker analysis of linkage and/or linkage disequilibrium on a mixture of pedigrees and singletons when the mode of inheritance cannot be accurately specified. (Additional information can be obtained from these web sites: ftp://llinkage.cpmc.columbia.edu/software/analyze or ftp://ftp.well.ox.ac.uk/pub/genetics/analyze). Am. J. Hum. Genet. 2000;. in press.
7. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid. Res. 31:1990;545-548.
8. Liao A., Nitsch R.M., Greenberg S.M., Finckh U., Blacker D., Albert M., Rebeck G.W., Gomez-Isla T., Clatworthy A., Binetti G., Hock C., Mueller-Thomsen T., Mann U., Zuchowski K., Beisiegel U., Staehelin H., Growdon J.H., Tanzi R.E., Hyman B.T. Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum. Mol. Genet. 7:1998;1953-1956.
9. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
10. Pericak-Vance M.A., Bass M.P., Yamaoka L.H., Gaskell P.C., Scott W.K., Terwedow H.A., Menold M.M., Conneally P.M., Small G.W., Vance J.M., Saunders A.M., Roses A.D., Haines J.L. Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome. J. Am. Med. Assoc. 278:1997;1237-1241.
11. Poller W., Faber J.P., Klobeck G., Olek K. Cloning of the human alpha 2-macroglobulin gene and detection of mutations in two functional domains: the bait region and the thiolester site. Hum. Genet. 88:1992;313-319.
12. Rogaeva E., Premkumar S., Song Y., Sorbi S., Brindle N., Paterson A., Duara R., Levesque G., Yu G., Nishimura M., Ikeda M., O'Toole C., Kawarai T., Jorge R., Vilarino D., Bruni A.C., Farrer L.A., St. George-Hyslop P.H. Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. J. Am. Med. Assoc. 280:1998;614-618.
13. Rogaeva E.A., Premkumar S., Grubber J., Serneels L., Scott W.K., Kawarai T., Song Y., Hill D.L., Abou-Donia S.M., Martin E.R., Vance J.J., Yu G., Orlacchio A., Pei Y., Nishimura M., Supala A., Roberge B., Saunders A.M., Roses A.D., Schmechel D., Crane-Gatherum A., Sorbi S., Bruni A., Small G.W., Conneally M.P., Haines J.L., Van Leuven F., St. George-Hyslop P.H., Pericak-Vance M.A., Farrer L.A. An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nat. Genet. 22:1999;19-22.
14. Rosenthal N., Schwartz R.S. In search of perverse polymorphisms. New. Engl. J. Med. 338:1998;122-124.
15. Rudrasingham V., Wavrant-De Vrieze F., Lambert J.C., Chakraverty S., Kehoe P., Crook R., Amouyel P., Wu W., Rice F., Perez-Tur J., Frigard B., Morris J.C., Carty S., Petersen R., Cottel D., Tunstall N., Holmans P., Lovestone S., Chartier-Harlin M.C., Goate A., Hardy J., Owen M.J., Williams J. Alpha-2 macroglobulin gene and Alzheimer disease (discussion pp. 21-2). Nat. Genet. 22:1999;17-19.
16. Spielman R.S., Ewens W.J. A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test. Am. J. Hum. Genet. 62:1998;450-458.
17. Thompson G. Identifying complex disease genes: Progress and paradigms. Nat. Genet. 8:1994;108-110.
18. Wavrant-DeVrieze F., Rudrasingham V., Lambert J.C., Chakraverty S., Kehoe P., Crook R., Amouyel P., Wu W., Holmans P., Rice F., Perez-Tur J., Frigard B., Morris J.C., Carty S., Cottel D., Tunstall N., Lovestone S., Petersen R.C., Chartier-Harlin M.C., Goate A., Owen M.J., Williams J., Hardy J. No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease. Neurosci. Lett. 262:1999;137-139.
19. Wu W.S., Holmans P., Wavrant-DeVrieze F., Shears S., Kehoe P., Crook R., Booth J., Williams N., Perez-Tur J., Roehl K., Fenton I., Chartier-Harlin M.C., Lovestone S., Williams J., Hutton M., Hardy J., Owen M.J., Goate A. Genetic studies on chromosome 12 in late-onset Alzheimer disease. J. Am. Med. Assoc. 280:1998;619-622.